DE68914498D1 - Kombination von Phenäthanolamin und Wachstumshormon. - Google Patents
Kombination von Phenäthanolamin und Wachstumshormon.Info
- Publication number
- DE68914498D1 DE68914498D1 DE68914498T DE68914498T DE68914498D1 DE 68914498 D1 DE68914498 D1 DE 68914498D1 DE 68914498 T DE68914498 T DE 68914498T DE 68914498 T DE68914498 T DE 68914498T DE 68914498 D1 DE68914498 D1 DE 68914498D1
- Authority
- DE
- Germany
- Prior art keywords
- growth hormone
- phenethanolamine
- combination
- cimaterol
- ractopamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000018997 Growth Hormone Human genes 0.000 title abstract 3
- 108010051696 Growth Hormone Proteins 0.000 title abstract 3
- 239000000122 growth hormone Substances 0.000 title abstract 3
- ULSIYEODSMZIPX-UHFFFAOYSA-N phenylethanolamine Chemical compound NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 title 1
- 229950006768 phenylethanolamine Drugs 0.000 title 1
- BSDXBEZQZYKYHH-UHFFFAOYSA-N 1-(6-aminopyridin-3-yl)-2-(4-phenylbutan-2-ylamino)ethanol Chemical compound C=1C=C(N)N=CC=1C(O)CNC(C)CCC1=CC=CC=C1 BSDXBEZQZYKYHH-UHFFFAOYSA-N 0.000 abstract 2
- BUXRLJCGHZZYNE-UHFFFAOYSA-N 2-amino-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzonitrile Chemical compound CC(C)NCC(O)C1=CC=C(N)C(C#N)=C1 BUXRLJCGHZZYNE-UHFFFAOYSA-N 0.000 abstract 2
- 241000282898 Sus scrofa Species 0.000 abstract 2
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 abstract 2
- 229950010971 cimaterol Drugs 0.000 abstract 2
- 229960001117 clenbuterol Drugs 0.000 abstract 2
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- YJQZYXCXBBCEAQ-UHFFFAOYSA-N ractopamine Chemical compound C=1C=C(O)C=CC=1C(O)CNC(C)CCC1=CC=C(O)C=C1 YJQZYXCXBBCEAQ-UHFFFAOYSA-N 0.000 abstract 2
- 229940074095 ractopamine Drugs 0.000 abstract 2
- 229960002052 salbutamol Drugs 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Husbandry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Birds (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Feed For Specific Animals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16467588A | 1988-03-07 | 1988-03-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE68914498D1 true DE68914498D1 (de) | 1994-05-19 |
| DE68914498T2 DE68914498T2 (de) | 1994-08-18 |
Family
ID=22595564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE68914498T Expired - Fee Related DE68914498T2 (de) | 1988-03-07 | 1989-03-02 | Kombination von Phenäthanolamin und Wachstumshormon. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0333349B1 (de) |
| JP (1) | JP2780994B2 (de) |
| KR (1) | KR0129755B1 (de) |
| AT (1) | ATE104143T1 (de) |
| CA (1) | CA1336886C (de) |
| DE (1) | DE68914498T2 (de) |
| DK (1) | DK173510B1 (de) |
| ES (1) | ES2061974T3 (de) |
| HU (1) | HU204696B (de) |
| IE (1) | IE63407B1 (de) |
| IL (1) | IL89479A (de) |
| NZ (1) | NZ228197A (de) |
| PH (1) | PH26226A (de) |
| ZA (1) | ZA891588B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5453418A (en) * | 1988-03-07 | 1995-09-26 | Eli Lilly And Company | Ractopamine and growth hormone combinations |
| US6429186B1 (en) | 1991-05-10 | 2002-08-06 | Genentech, Inc. | Ligand antagonists for treatment of breast cancer |
| EP0586549B1 (de) | 1991-05-10 | 2000-09-20 | Genentech, Inc. | Auswählen von agonisten und antagonisten von liganden |
| US5216029A (en) * | 1991-11-26 | 1993-06-01 | Eli Lilly And Company | Fish production |
| US5595752A (en) * | 1994-07-01 | 1997-01-21 | Monsanto Company | Increasing dressing percentage and carcass weight in finishing beef cattle |
| CN103100237B (zh) * | 2012-12-31 | 2015-12-02 | 南宁市蓝光生物技术有限公司 | 微型高效莱克多巴胺免疫亲和纯化富集柱制备及应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4690951A (en) * | 1983-01-31 | 1987-09-01 | Eli Lilly And Company | Growth promotion |
| US4792546A (en) * | 1986-12-05 | 1988-12-20 | American Cyanamid Company | Method for increasing weight gains and reducing deposition of fat in animals |
| IE60964B1 (en) * | 1986-12-11 | 1994-09-07 | Roussel Uclaf | Zootechnical compositions containing a beta-adrenergic |
-
1989
- 1989-03-01 CA CA000592486A patent/CA1336886C/en not_active Expired - Fee Related
- 1989-03-01 ZA ZA891588A patent/ZA891588B/xx unknown
- 1989-03-02 AT AT89302096T patent/ATE104143T1/de not_active IP Right Cessation
- 1989-03-02 DE DE68914498T patent/DE68914498T2/de not_active Expired - Fee Related
- 1989-03-02 EP EP89302096A patent/EP0333349B1/de not_active Expired - Lifetime
- 1989-03-02 NZ NZ228197A patent/NZ228197A/en unknown
- 1989-03-02 ES ES89302096T patent/ES2061974T3/es not_active Expired - Lifetime
- 1989-03-03 IL IL8947989A patent/IL89479A/en not_active IP Right Cessation
- 1989-03-06 KR KR1019890002727A patent/KR0129755B1/ko not_active IP Right Cessation
- 1989-03-06 DK DK198901061A patent/DK173510B1/da not_active IP Right Cessation
- 1989-03-06 IE IE71689A patent/IE63407B1/en not_active IP Right Cessation
- 1989-03-06 HU HU891099A patent/HU204696B/hu not_active IP Right Cessation
- 1989-03-06 PH PH38287A patent/PH26226A/en unknown
- 1989-03-07 JP JP1054833A patent/JP2780994B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU617155B2 (en) | 1991-11-21 |
| KR0129755B1 (ko) | 1998-04-09 |
| DK106189D0 (da) | 1989-03-06 |
| EP0333349A3 (en) | 1990-12-05 |
| HUT49281A (en) | 1989-09-28 |
| PH26226A (en) | 1992-04-01 |
| EP0333349A2 (de) | 1989-09-20 |
| IE63407B1 (en) | 1995-04-19 |
| EP0333349B1 (de) | 1994-04-13 |
| AU3102789A (en) | 1989-09-07 |
| DK106189A (da) | 1989-10-20 |
| IL89479A (en) | 1994-08-26 |
| IL89479A0 (en) | 1989-09-10 |
| NZ228197A (en) | 1991-07-26 |
| ZA891588B (en) | 1990-11-28 |
| DE68914498T2 (de) | 1994-08-18 |
| KR890014099A (ko) | 1989-10-21 |
| JPH01268643A (ja) | 1989-10-26 |
| DK173510B1 (da) | 2001-01-15 |
| IE890716L (en) | 1989-09-07 |
| ATE104143T1 (de) | 1994-04-15 |
| CA1336886C (en) | 1995-09-05 |
| HU204696B (en) | 1992-02-28 |
| ES2061974T3 (es) | 1994-12-16 |
| JP2780994B2 (ja) | 1998-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3687551D1 (de) | Implantate mit verzoegerter abgabe fuer die anwendung von rekombinanten wachstumshormonen. | |
| CS623787A3 (en) | Therapeutic system for applying active substances to skin, process forpreparing thereof and its use | |
| BR8801242A (pt) | Processo de preparar uma composicao para fornecer uma quantidade efetiva de uma dose constante de um ingrediente ativo a um animal e a respectiva composicao | |
| DE69218406T2 (de) | Verwendung von menschlichem igf-i | |
| DE69008476D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose. | |
| DE3772521D1 (de) | Insulinzubereitung fuer nicht-parenterale verabreichung. | |
| EP0289186A3 (de) | Methode zur Erhöhung der Wachstumsrate und zur Steigerung der Futterleistungsfähigkeit bei Vieh | |
| DE3867903D1 (de) | Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle und diese mischkristalle enthaltende pharmazeutische mittel. | |
| DE68914498D1 (de) | Kombination von Phenäthanolamin und Wachstumshormon. | |
| SE8204874D0 (sv) | Farmaceutiska preparat, innefattande humant insulin och humant proinsulin | |
| CS151887A2 (en) | Method of sound, physiologically normal farming animal's mamma parenchyma's growth increase | |
| GB2198351B (en) | Improvements in or relating to the use of epidermal growth factor for enhancing the uptake of iron in vivo. | |
| DE3476736D1 (en) | Use of an antihypoxidoticum with cerebral and peripheral effect | |
| RU97112615A (ru) | Способ лечения расплода пчел, больных аскосферозом | |
| BG50927A3 (en) | A process for stabilisied growth-stimulating hormone preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |